FR2377199A2 - Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire - Google Patents

Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire

Info

Publication number
FR2377199A2
FR2377199A2 FR7700811A FR7700811A FR2377199A2 FR 2377199 A2 FR2377199 A2 FR 2377199A2 FR 7700811 A FR7700811 A FR 7700811A FR 7700811 A FR7700811 A FR 7700811A FR 2377199 A2 FR2377199 A2 FR 2377199A2
Authority
FR
France
Prior art keywords
compsn
hymecromone
chenodeoxy
treating
lower cost
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7700811A
Other languages
English (en)
French (fr)
Other versions
FR2377199B2 (US07608600-20091027-C00054.png
Inventor
Jean-Claude Lechevin
Jean-Noel Treilles
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sante SAS
Original Assignee
LIPHA SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LIPHA SAS filed Critical LIPHA SAS
Priority to FR7700811A priority Critical patent/FR2377199A2/fr
Priority to NZ184623A priority patent/NZ184623A/xx
Priority to IL52502A priority patent/IL52502A/xx
Priority to AU26953/77A priority patent/AU2695377A/en
Priority to IE1445/77A priority patent/IE45303B1/en
Priority to GB29514/77A priority patent/GB1541165A/en
Priority to JP8307577A priority patent/JPS5312427A/ja
Publication of FR2377199A2 publication Critical patent/FR2377199A2/fr
Application granted granted Critical
Publication of FR2377199B2 publication Critical patent/FR2377199B2/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7700811A 1976-07-13 1977-01-13 Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire Granted FR2377199A2 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR7700811A FR2377199A2 (fr) 1977-01-13 1977-01-13 Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire
NZ184623A NZ184623A (en) 1976-07-13 1977-07-11 Pharmaceutical composition for treatment of billiary lithiasis
IL52502A IL52502A (en) 1976-07-13 1977-07-11 Pharmaceutical compositions for treating bile stones, comprising chenodeoxycholic acid
AU26953/77A AU2695377A (en) 1976-07-13 1977-07-12 Medicinal composition for the treatment of biliary lithiasis
IE1445/77A IE45303B1 (en) 1976-07-13 1977-07-12 Composition for treating biliary lithiasis
GB29514/77A GB1541165A (en) 1976-07-13 1977-07-13 Composition for treating biliary lithiasis
JP8307577A JPS5312427A (en) 1976-07-13 1977-07-13 Treating agent for galllstone disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7700811A FR2377199A2 (fr) 1977-01-13 1977-01-13 Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire

Publications (2)

Publication Number Publication Date
FR2377199A2 true FR2377199A2 (fr) 1978-08-11
FR2377199B2 FR2377199B2 (US07608600-20091027-C00054.png) 1979-04-20

Family

ID=9185422

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7700811A Granted FR2377199A2 (fr) 1976-07-13 1977-01-13 Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire

Country Status (1)

Country Link
FR (1) FR2377199A2 (US07608600-20091027-C00054.png)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2453649A1 (fr) * 1978-12-15 1980-11-07 Lehner Ag Composition pharmaceutique a action prolongee contenant des acides biliaires utile notamment pour la lyse des calculs

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2453649A1 (fr) * 1978-12-15 1980-11-07 Lehner Ag Composition pharmaceutique a action prolongee contenant des acides biliaires utile notamment pour la lyse des calculs

Also Published As

Publication number Publication date
FR2377199B2 (US07608600-20091027-C00054.png) 1979-04-20

Similar Documents

Publication Publication Date Title
EP0136011A3 (en) A method of hormonal treatment of peri-menopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor
DK0606012T3 (da) Sammensætninger indeholdende cholesterylestere af umættede fedtsyrer
PH14287A (en) Naphthyridine derivatives,pharmaceutical compositions containing same and method of treatment thereof
JPS5753449A (en) 2-hydroxy-5-phenylazobenzoic acid derivative, manufacture and medicinal composition
IL62044A (en) Polyhydronaphthylethyl tetrahydro-2h-pyran-2-one derivatives and hydroxy acids and esters thereof,their preparation and pharmaceutical compositions containing them
NO940277L (no) Triglycerider og blandinger av slike
NZ195517A (en) Imidazole-5-acetic acid derivatives and pharmaceutical compositions
IL56991A (en) 4-halo-3-oxoandrost-4-ene-17 beta-thiocarboxylic acid esters,their preparation and pharmaceutical compositions containing them
FR2358144A1 (fr) Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire
PH13213A (en) Retinoic acid esters of steroids of the pregnone series,their use in the treatment of acne and pharmaceutical formulations useful therefor
AU563273B2 (en) Composition containing an essential fatty acid and niacin and/or a bile salt binder
FR2377199A2 (fr) Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire
IL57072A0 (en) 1,3-dibenzoic acid esters of 17 -ethynyl-7 methyl- 1,3,5(10)-oestratrene-1,3,17 -triol and their manufacture and use
IL85776A (en) Pharmaceutical compositions comprising certain selenium containing algae and c18-c22 unsaturated acids and their preparation,used for treating conditions of the heart and cardiovascular system
ZA784083B (en) Fatty acid and derivatives thereof,and formulations containing them for use in treatment or prophyllaxis of thrombo-embolic conditions
IL65922A0 (en) Preparation of apovincaminic acid esters,certain novel optically active derivatives thereof and pharmaceutical compositions containing them
IL53926A (en) 5-substituted-2-oxo-2h(1,2,4)-oxadiazolo (2,3-a)-pyrimidine-7-cabamic acid esters,their manufacture and pharmaceutical compositions containing them
JPS5350316A (en) Drug composition for oral administration
DE3470534D1 (en) Diniflumate of morpholinoethyl ester of niflumic acid, its preparation, and its use in analgesic and antiinflammatory pharmaceutical compositions
PH15995A (en) 1-naphtyl acetic acid derivatives and their therapeutic composition
EP0222099A3 (en) Alpha-(aminoalkyl)-arylacetic acid derivatives
JPS57122068A (en) N-pyrimidinyl-carbamic acid ester, manufacture and medicine containing same
PH13873A (en) Substituted thenoylacetic acid and esters,their pharmaceutical composition and method of use
KR880010762A (ko) 소화성궤양의 치료방법 및 치료용 합성물(Composition and Method for Treatment of peptic Ulcers)
PT80214B (en) Process for the preparation of a pharmaceutical composition containing 9alpha,11beta-dichloro 16alpha-methyl 21-oxycarbonyldicyclohexyl-methyloxi-pregne-1,4-diene 3,20-dione as active agent and an inert product as excipient appropriate to permit r said composition to be used in the rectum or colon